Загрузка...
Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia
The aim of the present study was to investigate the efficacy of a potassium-competitive acid blocker (PCAB) named vonoprazan (VPZ) for improving symptoms in patients with reflux esophagitis (RE), non-erosive reflux disease (NERD), and functional dyspepsia (FD). A hospital-based, retrospective study...
Сохранить в:
| Опубликовано в: : | Biomed Rep |
|---|---|
| Главные авторы: | , , , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
D.A. Spandidos
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5351306/ https://ncbi.nlm.nih.gov/pubmed/28357069 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/br.2016.828 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|